A controllable aptamer-based self-assembled DNA dendrimer for high affinity targeting, bioimaging and drug delivery

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Zhang, Huimin ^a   Ma, Yanli ^a   Xie, Yi ^a   An, Yuan ^a   Huang, Yishun ^a   Zhu, Zhi ^a   Yang, Chaoyong James ^a  

^a XIAMEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; APTAMER; DENDRIMER; DOXORUBICIN; FLUORESCEIN ISOTHIOCYANATE; NANOMATERIAL;

AGAR GEL ELECTROPHORESIS; CELL DEATH; CELL FRACTIONATION; CHEMISTRY; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEM; DRUG EFFECTS; HUMAN; METABOLISM; PROCEDURES; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APTAMERS, NUCLEOTIDE; CELL DEATH; CELL LINE, TUMOR; DENDRIMERS; DIAGNOSTIC IMAGING; DOXORUBICIN; DRUG DELIVERY SYSTEMS; ELECTROPHORESIS, AGAR GEL; FLUORESCEIN-5-ISOTHIOCYANATE; HUMANS; NANOSTRUCTURES; SUBCELLULAR FRACTIONS;

EID: 84929223490     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep10099     Document Type: Article

References (24)

1. Peer, D. et al. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2, 751-760, doi:DOI 10.1038/nnano.2007.387 (2007).
2. Li, X., Huang, J., Tibbits, G. F. & Li, P. C. Real-time monitoring of intracellular calcium dynamic mobilization of a single cardiomyocyte in a microfuidic chip pertaining to drug discovery. Electrophoresis 28, 4723-4733, doi:10.1002/elps.200700312 (2007).
3. Sun, T. et al. Engineered Nanoparticles for Drug Delivery in Cancer Terapy. Angew. Chem. Int. Ed. Engl., 53, 12320-12364, doi:10.1002/anie.201403036 (2014).
4. Farokhzad, O. C. & Langer, R. Nanomedicine: Developing smarter therapeutic and diagnostic modalities. Adv. Drug Deliver Rev. 58, 1456-1459, doi:10.1016/j.addr.2006.09.011 (2006).
5. Tian, J. et al. Cell-specifc and pH-activatable rubyrin-loaded nanoparticles for highly selective near-infrared photodynamic therapy against cancer. J. Am. Chem. Soc. 135, 18850-18858, doi:10.1021/ja408286k (2013).
6. Yezhelyev, M. V. et al. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet. Oncol. 7, 657-667, doi:10.1016/S1470-2045(06)70793-8 (2006).
7. Petros, R. A. & DeSimone, J. M. Strategies in the design of nanoparticles for therapeutic applications. Nat. Rev. Drug Discov. 9, 615-627, doi:10.1038/nrd2591 (2010).
8. Davis, M. E., Chen, Z. G. & Shin, D. M. Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat. Rev. Drug Discov. 7, 771-782, doi:10.1038/nrd2614 (2008).
9. Tian, J. et al. A multifunctional nanomicelle for real-time targeted imaging and precise near-infrared cancer therapy. Angew. Chem. Int. Ed. Engl. 53, 9544-9549, doi:10.1002/anie.201405490 (2014).
10. Pinheiro, A. V., Han, D., Shih, W. M. & Yan, H. Challenges and opportunities for structural DNA nanotechnology. Nat. Nanotechnol. 6, 763-772, doi:10.1038/nnano.2011.187 (2011).
11. Chhabra, R., Sharma, J., Liu, Y., Rinker, S. & Yan, H. DNA self-assembly for nanomedicine. Adv. Drug Deliver Rev. 62, 617-625, doi:10.1016/j.addr.2010.03.005 (2010).
12. Li, J. et al. Self-assembled multivalent DNA nanostructures for noninvasive intracellular delivery of immunostimulatory CpG oligonucleotides. Acs Nano 5, 8783-8789, doi:10.1021/nn202774x (2011).
13. Lee, H. et al. Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat. Nanotechnol. 7, 389-393, doi:10.1038/nnano.2012.73 (2012).
14. Zhang, Q. et al. DNA Origami as an In Vivo Drug Delivery Vehicle for Cancer Terapy. Acs Nano 8, 6633-6643, doi:10.1021/Nn502058j (2014).
15. Mintzer, M. A. & Grinstaf, M. W. Biomedical applications of dendrimers: a tutorial. Chem. Soc. Rev. 40, 173-190, doi:10.1039/B901839p (2011).
16. Rattanakiat, S., Nishikawa, M., Funabashi, H., Luo, D. & Takakura, Y. The assembly of a short linear natural cytosine-phosphate-guanine DNA into dendritic structures and its efect on immunostimulatory activity. Biomaterials 30, 5701-5706, doi:10.1016/j.biomaterials.2009.06.053 (2009).
17. Li, J. et al. Self-assembly of DNA Nanohydrogels with Controllable Size and Stimuli-Responsive Property for Targeted Gene Regulation Terapy. J. Am. Chem. Soc. 137, 1412-1415, doi:10.1021/ja512293f (2015).
18. Grabow, W. W. & Jaeger, L. siRNA DELIVERY Loaded-up microsponges. Nat. Mater. 11, 268-269, doi:10.1038/Nmat3286 (2012).
19. Tuerk, C. & Gold, L. Systematic Evolution of Ligands by Exponential Enrichment-Rna Ligands to Bacteriophage-T4 DNA-Polymerase. Science 249, 505-510, doi:10.1126/science.2200121 (1990).
20. Vinkenborg, J. L., Karnowski, N. & Famulok, M. Aptamers for allosteric regulation. Nat. Chem. Biol. 7, 519-527, doi:10.1038/Nchembio.609 (2011).
21. Yang, L. et al. Aptamer-conjugated nanomaterials and their applications. Adv. Drug Deliver Rev. 63, 1361-1370, doi:10.1016/j. addr.2011.10.002 (2011).
22. Shangguan, D. et al. Aptamers evolved from live cells as efective molecular probes for cancer study. P. Natl. Acad. Sci. USA 103, 11838-11843, doi:10.1073/pnas.0602615103 (2006).
23. Zhou, T. et al. pH-Responsive Size-Tunable Self-Assembled DNA Dendrimers. Angew. Chem. Int. Ed. Engl. 51, 11271-11274, doi:10.1002/anie.201205862 (2012).
24. Meng, H. M. et al. DNA dendrimer: an efcient nanocarrier of functional nucleic acids for intracellular molecular sensing. Acs Nano 8, 6171-6181, doi:10.1021/nn5015962 (2014).